×
Accedi
Iniziamo
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Esplora tutte le categorie
Report -
Farmaci Antidiabetici e Rischio Cardio-Nefro- Vascolare...Renal Outcomes with Empagliflozin 7 EMPA-REG RENAL (N=7020) *Doubling of SCr + eGFR ≤45 mL/min/1.73 m 2, initiation of renal
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form